| Histopathological findings in brain tissue obtained during epilepsy surgery I Blumcke, R Spreafico, G Haaker, R Coras, K Kobow, CG Bien, M Pfäfflin, ... New England Journal of Medicine 377 (17), 1648-1656, 2017 | 746 | 2017 |
| Mutations in the Gene Encoding KRIT1, a Krev-1/rap1a Binding Protein, Cause Cerebral Cavernous Malformations (CCM1) T Sahoo, EW Johnson, JW Thomas, PM Kuehl, TL Jones, CG Dokken, ... Human molecular genetics 8 (12), 2325-2333, 1999 | 409 | 1999 |
| A fast pathway for fear in human amygdala C Mendez-Bertolo, S Moratti, R Toledano, F Lopez-Sosa, ... Nature neuroscience 19 (8), 1041-1049, 2016 | 376 | 2016 |
| Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest EW Johnson, J Dubovsky, SS Rich, CA O'Donovan, HT Orr, VE Anderson, ... Human molecular genetics 7 (1), 63-67, 1998 | 245 | 1998 |
| Ictal semiology in hippocampal versus extrahippocampal temporal lobe epilepsy. A Gil-Nagel, MW Risinger Brain: a journal of neurology 120 (1), 183-192, 1997 | 237 | 1997 |
| Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy MJ Brodie, H Lerche, A Gil-Nagel, C Elger, S Hall, P Shin, V Nohria, ... Neurology 75 (20), 1817-1824, 2010 | 231 | 2010 |
| Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial I Miller, IE Scheffer, B Gunning, R Sanchez-Carpintero, A Gil-Nagel, ... JAMA neurology 77 (5), 613-621, 2020 | 219 | 2020 |
| Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study HJ Lamberink, WM Otte, I Blümcke, KPJ Braun, M Aichholzer, I Amorim, ... The Lancet Neurology 19 (9), 748-757, 2020 | 211 | 2020 |
| Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial R Nabbout, A Mistry, S Zuberi, N Villeneuve, A Gil-Nagel, ... JAMA neurology 77 (3), 300-308, 2020 | 208 | 2020 |
| Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures A Gil‐Nagel, J Lopes‐Lima, L Almeida, J Maia, P Soares‐da‐Silva, ... Acta Neurologica Scandinavica 120 (5), 281-287, 2009 | 199 | 2009 |
| Epidemiological profile of epilepsy in low income populations C Espinosa-Jovel, R Toledano, Á Aledo-Serrano, I García-Morales, ... Seizure 56, 67-72, 2018 | 156 | 2018 |
| Antiepileptic drug therapy: does mechanism of action matter? MJ Brodie, A Covanis, A Gil-Nagel, H Lerche, E Perucca, GJ Sills, ... Epilepsy & Behavior 21 (4), 331-341, 2011 | 142 | 2011 |
| Epilepsy and cannabidiol: a guide to treatment A Arzimanoglou, U Brandl, JH Cross, A Gil‐Nagel, L Lagae, CJ Landmark, ... Epileptic Disorders 22 (1), 1-14, 2020 | 136 | 2020 |
| Current standards of neuropsychological assessment in epilepsy surgery centers across Europe VL Vogt, M Äikiä, A Del Barrio, P Boon, C Borbély, E Bran, K Braun, ... Epilepsia 58 (3), 343-355, 2017 | 119 | 2017 |
| Effect of lamotrigine on sexual function in patients with epilepsy A Gil-Nagel, F Lopez-Munoz, JM Serratosa, I Moncada, P Garcia-Garcia, ... Seizure 15 (3), 142-149, 2006 | 118 | 2006 |
| Mild malformation of cortical development with oligodendroglial hyperplasia in frontal lobe epilepsy: a new clinico‐pathological entity J Schurr, R Coras, K Rössler, T Pieper, M Kudernatsch, H Holthausen, ... Brain Pathology 27 (1), 26-35, 2017 | 107 | 2017 |
| Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. EW Johnson, LM Iyer, SS Rich, HT Orr, A Gil-Nagel, JH Kurth, ... Genome Research 5 (4), 368-380, 1995 | 99 | 1995 |
| Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe BE Mouthaan, M Rados, P Barsi, P Boon, DW Carmichael, E Carrette, ... Epilepsia 57 (5), 770-776, 2016 | 96 | 2016 |
| Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: integrated analysis of pooled data from double‐blind phase III … A Gil‐Nagel, C Elger, E Ben‐Menachem, P Halász, J Lopes‐Lima, ... Epilepsia 54 (1), 98-107, 2013 | 94 | 2013 |
| Adverse effects of antiepileptic drugs R Toledano, A Gil-Nagel Seminars in neurology 28 (03), 317-327, 2008 | 88 | 2008 |
